MEGAN BRUXER: Open Payments
NPI 1346987336 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,265 in 143 payments from 45 companies in 2025. Trend: 2023 $2,076 · 2024 $2,922 · 2025 $3,265
Food & beverage: $3,122Education: $143
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $438 |
| Janssen Biotech, Inc. | 16 | $291 |
| Daiichi Sankyo Inc. | 8 | $221 |
| Novartis Pharmaceuticals Corporation | 10 | $212 |
| ABBVIE INC. | 7 | $149 |
| Incyte Corporation | 6 | $147 |
| PFIZER INC. | 7 | $127 |
| Lilly USA, LLC | 4 | $108 |
| Regeneron Healthcare Solutions, Inc. | 4 | $107 |
| BeOne Medicines USA, Inc. | 4 | $105 |
Products named: Enhertu, IMFINZI, MONJUVI, VERZENIO, LIBTAYO, KEYTRUDA, ERLEADA, DARZALEX.
Industry payments across AZ — which companies pay providers there.
